Clinical trial
Characterization of Methylation Patterns in Lung Cancer
NCT02373917 is registered in ClinicalTrials.gov with Nucleix Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of Methylation Patterns in Lung Cancer
- Lead sponsor
- Nucleix Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- April 30, 2021
- Enrollment
- 683 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer